COMPARISON OF THE HEMODYNAMIC-EFFECTS OF ADENOSINE-MONOPHOSPHATE WITH SODIUM-NITROPRUSSIDE IN A CANINE MODEL OF ACUTE GLOBAL LEFT-VENTRICULAR DYSFUNCTION

被引:4
作者
FINEGAN, BA
CLANACHAN, AS
机构
[1] UNIV ALBERTA,DEPT ANAESTHESIA,EDMONTON T6G 2H4,ALBERTA,CANADA
[2] UNIV ALBERTA,DEPT PHARMACOL,EDMONTON T6G 2H4,ALBERTA,CANADA
关键词
ADENOSINE 5'-MONOPHOSPHATE; SODIUM NITROPRUSSIDE; CARDIAC OUTPUT; LEFT VENTRICULAR DYSFUNCTION; AFTERLOAD REDUCTION; VASODILATORS;
D O I
10.1111/j.1476-5381.1991.tb09848.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The haemodynamic effects of adenosine 5'-monophosphate (AMP) and sodium nitroprusside (SNP) were compared in anaesthetized dogs following the induction of acute left ventricular (LV) dysfunction. 2 LV dysfunction was induced by the intracoronary administration of glass microbeads until left ventricular end diastolic pressure (LVEDP) was increased from 5 to 15 mmHg. This was associated with a decrease in LV dP/dt and cardiac index (CI) of 30% and 27%, respectively, and an increase in systemic vascular resistance index (SVRI) of 37%. 3 Graded doses of AMP (100 to 1000-mu-g kg-1 min-1) or SNP (1 to 10-mu-g kg-1 min-1) reduced SVRI and increased CI in a dose-related manner. Heart rate was not altered by either agent. At doses that caused similar reductions in SVRI, CI was increased more by AMP than by SNP. 4 The mechanisms responsible for the greater elevation of CI by AMP relative to SNP may be related to its more selective arterial vasodilator activity. SNP reduced cardiac preload that limited the expected increase in CI. 5 The haemodynamic profile of AMP suggests that it may be useful in the pharmacological management of acute cardiac failure, either when used alone or in combination with positive inotropic agents and/or selective venodilators.
引用
收藏
页码:1691 / 1696
页数:6
相关论文
共 35 条
[1]   INTRACORONARY ADENOSINE ADMINISTERED AFTER REPERFUSION LIMITS VASCULAR INJURY AFTER PROLONGED ISCHEMIA IN THE CANINE MODEL [J].
BABBITT, DG ;
VIRMANI, R ;
FORMAN, MB .
CIRCULATION, 1989, 80 (05) :1388-1399
[2]   THE CARDIAC EFFECTS OF ADENOSINE [J].
BELARDINELLI, L ;
LINDEN, J ;
BERNE, RM .
PROGRESS IN CARDIOVASCULAR DISEASES, 1989, 32 (01) :73-97
[3]   EFFECT OF INFUSED ADENOSINE ON CARDIAC-OUTPUT AND SYSTEMIC RESISTANCE IN NORMAL SUBJECTS [J].
BUSH, A ;
BUSST, CM ;
CLARKE, B ;
BARNES, PJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (02) :165-171
[4]   EFFECTS OF VASODILATOR THERAPY FOR SEVERE PUMP FAILURE IN ACUTE MYOCARDIAL-INFARCTION ON SHORT-TERM AND LATE PROGNOSIS [J].
CHATTERJEE, K ;
SWAN, HJC ;
KAUSHIK, VS ;
JOBIN, G ;
MAGNUSSON, P ;
FORRESTER, JS .
CIRCULATION, 1976, 53 (05) :797-802
[5]   METABOLISM OF ADENINE-NUCLEOTIDES IN HUMAN-BLOOD [J].
COADE, SB ;
PEARSON, JD .
CIRCULATION RESEARCH, 1989, 65 (03) :531-537
[6]   THE VASODILATOR ROLE OF ADENOSINE [J].
COLLIS, MG .
PHARMACOLOGY & THERAPEUTICS, 1989, 41 (1-2) :143-162
[7]   HEMODYNAMIC-EFFECTS OF INOSINE - A NEW DRUG FOR FAILING HUMAN-HEART [J].
CZARNECKI, W ;
CZARNECKI, A .
PHARMACOLOGICAL RESEARCH, 1989, 21 (05) :587-594
[8]  
CZARNECKI W, 1983, CARDIOVASC RES, V12, P735
[9]   ADENOSINE - ELECTROPHYSIOLOGIC EFFECTS AND THERAPEUTIC USE FOR TERMINATING PAROXYSMAL SUPRA-VENTRICULAR TACHYCARDIA [J].
DIMARCO, JP ;
SELLERS, TD ;
BERNE, RM ;
WEST, GA ;
BELARDINELLI, L .
CIRCULATION, 1983, 68 (06) :1254-1263
[10]   INFUSION OF ADENOSINE PROVOKES MYOCARDIAL ISCHEMIA IN PATIENTS WITH ISCHEMIC HEART-DISEASE [J].
EDLUND, A ;
STRAAT, E ;
HENRIKSSON, P .
CLINICAL PHYSIOLOGY, 1989, 9 (03) :307-311